July 2026 · JAMA Study
Clinical Standards
This page contains affiliate links. We may earn a commission at no extra cost to you — see full disclosure below.
What the Secret Shopper Study Means for Clinical Standards Going Forward
The July 2026 JAMA secret shopper study found 45 of 49 telehealth GLP-1 platforms prescribed with minimal clinical oversight. From a clinical-standards perspective, here's what needs to change going forward — and what patients should expect from a properly run evaluation.
What genuine clinical oversight actually requires
- Individualized review of intake answers by a licensed clinician, not automated approval
- Screening for contraindications specific to GLP-1 therapy — personal or family history of medullary thyroid cancer, MEN 2 syndrome, pancreatitis
- A documented plan for follow-up, not a one-time transaction
- Willingness to decline or delay prescribing when something in the intake warrants further evaluation
Clinical standard: A properly conducted evaluation should occasionally result in a "not appropriate at this time" determination. If a platform's approval rate appears to be effectively 100% regardless of intake answers, that's a meaningful signal about the thoroughness of review.
Sesame Care From $29
A wide network of licensed physicians conducting individualized evaluations.
Prescribes FDA-approved brand-name medication only. Not a compounded provider.
Visit Sesame Care →Paid link
MEDVi $179/mo
Injectable and oral options.
⚠️ FDA Warning Letter on record. Consider alongside other factors when evaluating this provider.
Visit MEDVi →Paid link
What this means going forward
This study should raise the bar for the entire industry, not just flag bad actors after the fact. Patients evaluating a provider now have a concrete, published benchmark to measure any platform against — ask directly whether a clinician individually reviews your specific intake before approval.
Important: GLP-1 Doc earns affiliate commissions when you visit a provider through our links. This does not affect pricing or your care. Provider mentions are editorial. We are not a healthcare provider and do not prescribe medications. Always verify a provider's licensing in your state before starting treatment. Medical Disclaimer: Content is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication. Compounded GLP-1 medications are not FDA-approved.